Derived from early pandemic waves and needing recalibration for new variants, these renal markers and IL 10 could act as ...

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% ...

Age, spinal cord injury severity, C-reactive protein levels, urination modes, and pain severity all significantly impact incidence.

Researchers have found in a new study that the hemoglobin, albumin, lymphocyte, and platelet score serves as an independent predictor of 30-day readmission in patients with acute exacerbation ...

IBPS Clerk Mains Result 2025 OUT: The Institute of Banking Personnel Selection (IBPS) has declared the IBPS Clerk Mains ...

A closer look at a recent study reveals that vegans have significantly lower inflammatory markers than vegetarians and meat eaters ...

Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

KBRA assigns preliminary ratings to 102 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-4 (SEMT 2026-4), a $742.1 million prime RMBS transaction. The pool is comprised ...

The therapeutic landscape for polymyalgia rheumatica (PMR) has grown and will grow further, allowing prolonged use of glucocorticoids (GCs) to be minimized, Anisha B. Dua, MD, MPH, of Feinberg School ...

New data show bimekizumab is the first approved biologic to achieve superior outcomes in psoriatic arthritis vs an IL-23 ...